siRNA treatment lowers triglycerides in individuals along with uncommon health condition

.RESEARCH EMPHASIZE.19 September 2024.

Plozasiran minimized triglyceride amounts through 80% and also reduced the risk of pancreatitis in people with constant chylomicronemia, with or even without a hereditary diagnosis.